CHASON WORTHY: Open Payments
NPI 1881734556 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,631 in 119 payments from 20 companies in 2025. Trend: 2023 $2,123 · 2024 $2,599 · 2025 $2,631
Food & beverage: $2,523Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $683 |
| Regeneron Healthcare Solutions, Inc. | 8 | $249 |
| PFIZER INC. | 9 | $217 |
| Novartis Pharmaceuticals Corporation | 8 | $195 |
| UCB, Inc. | 6 | $174 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $172 |
| Janssen Biotech, Inc. | 4 | $167 |
| Galderma Laboratories, L.P. | 10 | $165 |
| Botanix SB Inc | 9 | $163 |
| GENZYME CORPORATION | 2 | $80 |
Products named: BOTOX, DUPIXENT, CIBINQO, SKYRIZI, Bimzelx, TREMFYA, SOFDRA, RINVOQ.
Industry payments across GA — which companies pay providers there.
